Fundraising FoxSweetBio
Memphis, US · Founded 2015 · Delaware corporation · 5 known investors
Find your way into SweetBio
Each arrow is one introduction. Sign up to fill in the first one.
305 people can intro you to Kayla
Ask Jan Bouten to introduce you to Kayla Rodriguez
You →Jan · together at SweetBio →Kayla
40 people can intro you to Isaac
Ask Jamie Chen to introduce you to Isaac Rodriguez
You →Jamie · together at SweetBio →Isaac
Sign up to find every way you can get introduced to SweetBio
- Your email: who you already know at SweetBio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the SweetBio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
SweetBio develops wound care dressings that combine collagen and Mānuka honey to help close chronic and acute non-healing wounds. Its products are used in clinical wound care settings and are reimbursed by Medicare, commercial plans, and available in VA and Department of Defense facilities.
Founders & leadership
SweetBio was founded in 2015 by Isaac Rodriguez and Kayla Rodriguez.
IR
Isaac RodriguezCo-Founder & Chief Science OfficerIsaac Rodriguez holds a doctorate and co-founded SweetBio, where he leads scientific strategy for the company's collagen and Mānuka honey wound care platform. He co-invented the honey-based biomaterial technology underlying the product line and has published research in regenerative medicine and biomaterials.
KR
Kayla RodriguezCo Founder & CEOCEO and co-founder of SweetBio, Kayla Rodriguez previously spent 10 years in medical device venture development and 6 years in operations strategy and mass market experience at Target Corp.
KG
Kevin GraffNamed on SEC filing
Investors · 5
Innova Memphis, Inc.listed by Innova Memphis, Inc.Memphis · $2Mvia Jan Bouten · board
How we know: Innova Memphis, Inc.'s portfolio page · a partner's Signal profile · board seat on SEC Form D · press coverage · the VCSheet dataset · Not right? Tell us
VamosVentureslisted by VamosVenturesLos Angeles · $2M
How we know: funding news · the VCSheet dataset · Not right? Tell us
InnovareportedCoral Gables
How we know: funding news · Not right? Tell us
MB Venture PartnersreportedMemphis
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 4 of 8 rounds · 2015–2024
▶$1.5MofferedApr 2024 · Other Health CareRule 506(b)
▶$1.5MofferedApr 2024 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kayla GraffExecutive Officer, Director
- Isaac RodriguezExecutive Officer, Director
- Kevin GraffExecutive Officer, Director
- Offering amount
- $1.5M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MofferedNov 2023 · Other Health CareRule 506(b)
▶$6MofferedNov 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Isaac RodriguezExecutive Officer, Director
- Jan BoutenDirector
- Kevin GraffExecutive Officer
- Kayla GraffExecutive Officer, Director
- Offering amount
- $6M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MofferedJan 2023 · Other Health CareRule 506(b)
▶$1MofferedJan 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jan BoutenDirector
- Isaac RodriguezExecutive Officer, Director
- Kayla GraffExecutive Officer, Director
- Kevin GraffExecutive Officer
- Offering amount
- $1M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$500KofferedApr 2022 · Other Health CareRule 506(b)
▶$500KofferedApr 2022 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Isaac RodriguezExecutive Officer, Director
- Kevin GraffExecutive Officer
- Jan BoutenDirector
- Kayla GraffExecutive Officer, Director
- Offering amount
- $500K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$590KraisedOct 2020 · 13 investors · Other Health CareRule 506(b)
▶$590KraisedOct 2020 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jan BoutenDirector
- Kayla GraffExecutive Officer, Director
- Isaac RodriguezExecutive Officer, Director
- Kevin GraffExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $590K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$803.6KraisedSep 2019 · 11 investors · Other Health CareRule 506(b)
▶$803.6KraisedSep 2019 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kayla GraffExecutive Officer, Director
- Jan BoutenDirector
- Kevin GraffExecutive Officer
- Isaac RodriguezExecutive Officer, Director
- Offering amount
- $810K
- Amount sold
- $803.6K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.1MraisedNov 2018 · 19 investors · Other Health CareRule 506(b)
▶$3.1MraisedNov 2018 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin GraffExecutive Officer
- Kayla GraffExecutive Officer, Director
- Jan BoutenDirector
- Isaac RodriguezExecutive Officer, Director
- Offering amount
- $3.3M
- Amount sold
- $3.1M
- Minimum investment
- $25K
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$100KraisedMay 2015 · 3 investors · Other Health CareRule 506(b)
▶$100KraisedMay 2015 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marsalas WhitakerExecutive Officer, Director
- Kevin GraffExecutive Officer
- Isaac RodriguezExecutive Officer, Director
- Kayla RodriguezExecutive Officer, Director
- Offering amount
- $100K
- Amount sold
- $100K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
BodyBioBodyBio is a third-generation family business that develops and manufactures science-backed dietary supplements and vitamins, including phosphatidylcholine (PC), butyrate, and detox products, aimed at cellular health and wellness. Products are made at the company's in-house facility with third-party testing.
BridgebioBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Sword BioSword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.
Companies working in the same space as SweetBio.
Frequently asked questions
- What does SweetBio do?
- SweetBio develops wound care dressings that combine collagen and Mānuka honey to help close chronic and acute non-healing wounds. Its products are used in clinical wound care settings and are reimbursed by Medicare, commercial plans, and available in VA and Department of Defense facilities.
- Who founded SweetBio?
- SweetBio was founded by Isaac Rodriguez, Kayla Rodriguez in 2015.
- Who are SweetBio's investors?
- SweetBio's investors include Innova Memphis, Inc., Launch Tennessee, VamosVentures, Innova, MB Venture Partners.
- How much funding has SweetBio raised?
- SweetBio has disclosed $4.6M raised across 4 of its 8 known rounds.
- Where is SweetBio headquartered?
- SweetBio is headquartered in Memphis, US.